Ticker Scorecard - MRVI Basics Company: Maravai LifeSciences Holdings, Inc. IPO Date: November 20, 2020 Sector: Healthcare Industry: Biotech Market Cap: $582.98M Activated in VL: True Average Daily Range Avg Daily Range: $0.56 | 2.70% Avg Daily Range (30 D): $0.18 | 3.66% Avg Daily Range (90 D): $0.20 | 3.42% Institutional Daily Volume Avg Daily Volume: 1.73M Avg Daily Volume (30 D): 2.1M Avg Daily Volume (90 D): 1.74M Trade Size Avg Trade Size (Sh.): 103 Avg Trade Size (Sh.) (30 D): 139 Avg Trade Size (Sh.) (90 D): 124 Institutional Trades Total Inst.Trades: 3,302 Avg Inst. Trade: $2.13M Avg Inst. Trade (30 D): $1.05M Avg Inst. Trade (90 D): $1.19M Avg Inst. Trade Volume: .11M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $3.22M Avg Closing Trade (30 D): $1.04M Avg Closing Trade (90 D): $1.18M Avg Closing Volume: 185.32K     News Jul 10, 2024 @ 12:31 PM Maravai LifeSciences To Host Earnings Conference C... Source: Globe Newswire May 17, 2024 @ 3:52 PM Maravai (MRVI) Advances in RNA Research With New C... Source: Zacks Equity Research May 9, 2024 @ 1:00 PM Where Maravai LifeSciences Stands With Analysts Source: Benzinga Insights May 9, 2024 @ 7:15 AM Maravai LifeSciences (MRVI) Q1 2024 Earnings Call ... Source: newsfeedback@fool.com (Motley Fool Transcribing) Apr 10, 2024 @ 8:05 PM Maravai LifeSciences To Host Earnings Conference C... Source: Maravai LifeSciences Holdings LLC Financials   TTM Q3 2024 Q2 2024 Basic EPS $-1.64 $-.7 $-.05 Diluted EPS $-1.64 $-.7 $-.05 Revenue $ 276.92M $ 65.2M $ 73.4M Gross Profit $ 128.38M $ 28.37M $ 35.13M Net Income / Loss $ -323.11M $ -175.96M $ -14.49M Operating Income / Loss $ -204.64M $ -169.11M $ -9.51M Cost of Revenue $ 148.54M $ 36.83M $ 38.27M Net Cash Flow $ -1.45M $ 4.99M $ 11.48M PE Ratio